JUMPptm

JUMPptm performs integrative identification and analysis of post-translational modifications (PTMs) from unenriched, ultra-deep whole-proteome mass spectrometry datasets to enable pan-PTM discovery and quantitative comparison across conditions.


Key Features:

  • Integration of multiple search engines: Integrates JUMP, MSFragger, and Comet to enhance sensitivity and specificity of PTM detection.
  • Iterative multi-stage strategy: Employs an iterative multi-stage strategy using de novo sequencing tags, customized database searches, peptide filtering techniques, and analysis of unassigned spectra.
  • Pan-PTM identification: Identifies a wide array of PTMs including phosphorylation, methylation, acetylation, and ubiquitination from unenriched datasets.
  • TMT-based quantification: Incorporates TMT-based quantification to evaluate abundance changes of PTM peptides across conditions or disease stages.

Scientific Applications:

  • Alzheimer's disease proteome analysis: Applied to deep brain proteome data from Alzheimer's disease samples, identifying 34,954 unique peptides carrying various PTMs.
  • Disease progression and mitochondrial acetylation: Identified 482 PTM peptides dysregulated across AD progression and a notable decrease in acetylation of multiple mitochondrial proteins.
  • Tau protein PTM mapping: Mapped 60 PTM sites on the Tau protein to characterize its modification landscape.

Methodology:

Integration of JUMP, MSFragger, and Comet; iterative multi-stage analysis using de novo sequencing tags, customized database searches, peptide filtering, and analysis of unassigned spectra; and TMT-based quantitative analysis.

Topics

Details

Cost:
Free of charge
Tool Type:
command-line tool, workflow
Operating Systems:
Mac, Linux
Programming Languages:
Perl, Python
Added:
11/8/2022
Last Updated:
11/24/2024

Operations

Publications

Poudel S, Vanderwall D, Yuan Z, Wu Z, Peng J, Li Y. JUMPptm: Integrated software for sensitive identification of post‐translational modifications and its application in Alzheimer's disease study. PROTEOMICS. 2022;23(3-4). doi:10.1002/pmic.202100369. PMID:36094355. PMCID:PMC9957936.

PMID: 36094355
PMCID: PMC9957936
Funding: - National Institutes of Health: P30CA021765, R01AG047928, R01AG053987, RF1AG064909, U19AG069701, U54NS110435